Skip to main content
Premium Trial:

Request an Annual Quote

Isis GeneTrove Strikes Functional Genomics Alliance with Amgen

NEW YORK, Jan. 3 — Isis Pharmaceuticals' GeneTrove division has launched a functional genomics alliance with Amgen, Isis said on Thursday.

 

Terms of the partnership call for Amgen to access Isis' functional genomics capabilities, including its antisense gene function and target validation expertise. The biotech behemoth will also apply technologies that Isis has developed with RNase H, a cellular enzyme that cleaves RNA in an RNA/DNA duplex.

 

The partnership builds upon the two companies' antisense drug-discovery collaboration, announced in December. Under that agreement, Amgen will develop and commercialize antisense drugs developed with Isis' gene target-inhibition chemistry. Isis, of Carlsbad, Calif., will receive milestone payments and royalties on any sales.

 

Isis' GeneTrove division, which provides antisense inhibitors for cell culture and animal disease models, is constructing a gene-function database that now includes results from inhibition studies of 10,000 human genes. Its other functionalization and target validation collaborations include agreements with Eli Lilly, Celera, Abbott, Johnson & Johnson, Aventis, and Chiron.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.